![]() |
Page History
...
Item | Who | Notes |
---|---|---|
Integrating environmental exposures of human cancer patients with canines | Matthew Breen |
|
Cellular Data (Flow Cytometry, Nano String Data) | Michael Olin |
|
Workshop for Immuno-Oncolgy (IO) Data Analytics | Erika Kim |
|
Non-Cancer Diseases | Toby Hecht | |
Pharma-specific Focus Group or Interviews | Amy Leblanc |
|
...
Warren - Representing the life trajectory of the dogs, attaching the specimens and data derived from those specimens at the appropriate point in that dog's life would be valuable. The pre and post- treatment specimens are one example (genomics, proteomics, microbiome). Let's say we have measurements from when the dog is born vs. end of life, how can we represent that data to better understand the trajectory of their lives and also carcinogenesis if applicable. Can we prepare the ICDC for hosting this type of data?
Toby and all – What immuno-oncology data to support. Several kinds of data are possible: Nanostring/sequence, immunohistochemistry (immune cell infiltration into tumor microenvironment), flow cytometry (immune cell subsets), serum cytokine levels. For flow cytometry, should raw data files be submitted, which would allow ICDC users to analyze data and draw gates themselves or should processed data be submitted, which would take up less space?
Toby - ICDC is a node in the CRDC so not sure non-cancer data is relevant. Aging and NEHES are the closest partners to us to focus on cancer, it will be a stretch to do other things.
...